• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子痫前期的肾脏受累:与血管内皮生长因子消融治疗的相似性。

Renal involvement in preeclampsia: similarities to VEGF ablation therapy.

作者信息

Müller-Deile Janina, Schiffer Mario

机构信息

Division of Nephrology and Hypertension, Department of Medicine, IFB-TX Hannover, Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany.

出版信息

J Pregnancy. 2011;2011:176973. doi: 10.1155/2011/176973. Epub 2010 Dec 23.

DOI:10.1155/2011/176973
PMID:21494322
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3066648/
Abstract

Glomerular VEGF expression is critical for the maintenance and function of an intact filtration barrier. Alterations in glomerular VEGF bioavailability result in endothelial as well as in podocyte damage. Renal involvement in preeclampsia includes proteinuria, podocyturia, elevated blood pressure, edema, glomerular capillary endotheliosis, and thrombotic microangiopathy. At least the renal signs, symptoms, and other evidence can sufficiently be explained by reduced VEGF levels. The aim of this paper was to summarize our pathophysiological understanding of the renal involvement of preeclampsia and point out similarities to the renal side effects of VEGF-ablation therapy.

摘要

肾小球血管内皮生长因子(VEGF)的表达对于完整滤过屏障的维持和功能至关重要。肾小球VEGF生物利用度的改变会导致内皮细胞以及足细胞损伤。子痫前期的肾脏受累包括蛋白尿、足细胞尿、血压升高、水肿、肾小球毛细血管内皮病变和血栓性微血管病。至少,肾脏的体征、症状和其他证据可以通过VEGF水平降低得到充分解释。本文的目的是总结我们对子痫前期肾脏受累的病理生理学理解,并指出与VEGF消融治疗肾脏副作用的相似之处。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1dc/3066648/9f960d3c9c1d/JP2011-176973.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1dc/3066648/9f960d3c9c1d/JP2011-176973.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1dc/3066648/9f960d3c9c1d/JP2011-176973.001.jpg

相似文献

1
Renal involvement in preeclampsia: similarities to VEGF ablation therapy.子痫前期的肾脏受累:与血管内皮生长因子消融治疗的相似性。
J Pregnancy. 2011;2011:176973. doi: 10.1155/2011/176973. Epub 2010 Dec 23.
2
Renin-angiotensin system transgenic mouse model recapitulates pathophysiology similar to human preeclampsia with renal injury that may be mediated through VEGF.肾素-血管紧张素系统转基因小鼠模型概括了类似于人类先兆子痫伴肾损伤的病理生理学,这种肾损伤可能通过血管内皮生长因子介导。
Am J Physiol Renal Physiol. 2017 Mar 1;312(3):F445-F455. doi: 10.1152/ajprenal.00108.2016. Epub 2016 Dec 7.
3
Decreased nephrin and GLEPP-1, but increased VEGF, Flt-1, and nitrotyrosine, expressions in kidney tissue sections from women with preeclampsia.子痫前期妇女肾组织切片中nephrin 和 GLEPP-1 表达减少,而 VEGF、Flt-1 和硝基酪氨酸表达增加。
Reprod Sci. 2009 Oct;16(10):970-9. doi: 10.1177/1933719109338630. Epub 2009 Jun 15.
4
From placenta to podocyte: vascular and podocyte pathophysiology in preeclampsia.从胎盘到足细胞:子痫前期的血管和足细胞病理生理学
Clin Nephrol. 2012 Sep;78(3):241-9. doi: 10.5414/cn107321.
5
The role of VEGF-A in glomerular development and function.血管内皮生长因子A(VEGF-A)在肾小球发育及功能中的作用。
Curr Opin Nephrol Hypertens. 2004 Jan;13(1):9-15. doi: 10.1097/00041552-200401000-00002.
6
Effects of angiogenic factors, antagonists, and podocyte injury on development of proteinuria in preeclampsia.血管生成因子、拮抗剂和足细胞损伤对先兆子痫蛋白尿发展的影响。
Reprod Sci. 2013 May;20(5):579-88. doi: 10.1177/1933719112459227. Epub 2012 Sep 18.
7
From Glomerular Endothelium to Podocyte Pathobiology in Preeclampsia: a Paradigm Shift.子痫前期中从肾小球内皮细胞到足细胞的病理生物学:范式转变
Curr Hypertens Rep. 2015 Jul;17(7):54. doi: 10.1007/s11906-015-0566-9.
8
VEGF inhibition and renal thrombotic microangiopathy.血管内皮生长因子抑制与肾血栓性微血管病
N Engl J Med. 2008 Mar 13;358(11):1129-36. doi: 10.1056/NEJMoa0707330.
9
Proteinuria in preeclampsia from a podocyte injury perspective.从足细胞损伤角度看子痫前期中的蛋白尿。
Curr Hypertens Rep. 2013 Dec;15(6):600-5. doi: 10.1007/s11906-013-0400-1.
10
Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model.可溶性 Flt-1 的减少可减轻小鼠模型的子痫前期样症状。
J Cell Mol Med. 2010 Jun;14(6B):1857-67. doi: 10.1111/j.1582-4934.2009.00820.x. Epub 2009 Jun 16.

引用本文的文献

1
Vascular injury in glomerulopathies: the role of the endothelium.肾小球疾病中的血管损伤:内皮的作用。
Front Nephrol. 2024 Dec 23;4:1396588. doi: 10.3389/fneph.2024.1396588. eCollection 2024.
2
Proteinuria is a clinical characteristic of intrahepatic cholestasis of pregnancy but it is not a marker of severity: A retrospective cohort study.蛋白尿是妊娠肝内胆汁淤积症的临床特征,但不是严重程度的标志物:一项回顾性队列研究。
PLoS One. 2024 Sep 11;19(9):e0310217. doi: 10.1371/journal.pone.0310217. eCollection 2024.
3
Effects of apelin on neonatal brain neurogenesis in L-NAME-induced maternal preeclampsia.

本文引用的文献

1
Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling.肾小球的结构和功能需要旁分泌,而不是自分泌,VEGF-VEGFR-2 信号。
J Am Soc Nephrol. 2010 Oct;21(10):1691-701. doi: 10.1681/ASN.2010030295. Epub 2010 Aug 5.
2
[Anti-vascular endothelial growth factor (VEGF) therapy: a new cause of secondary hypertension].[抗血管内皮生长因子(VEGF)治疗:继发性高血压的一个新病因]
Rev Prat. 2010 May 20;60(5):644-5, 647-8.
3
Rapid development of hypertension and proteinuria with cediranib, an oral vascular endothelial growth factor receptor inhibitor.
血管紧张素原诱导的子痫前期对新生鼠脑神经发生的影响。
Sci Rep. 2024 Aug 20;14(1):19347. doi: 10.1038/s41598-024-69326-2.
4
VASCULAR AND RENAL MECHANISMS OF PREECLAMPSIA.子痫前期的血管及肾脏机制
Curr Opin Physiol. 2023 Jun;33. doi: 10.1016/j.cophys.2023.100655. Epub 2023 Mar 2.
5
Maternal microvascular dysfunction during preeclamptic pregnancy.子痫前期妊娠期间的母体微血管功能障碍。
Clin Sci (Lond). 2021 May 14;135(9):1083-1101. doi: 10.1042/CS20200894.
6
Preeclampsia: Novel Mechanisms and Potential Therapeutic Approaches.子痫前期:新机制与潜在治疗方法
Front Physiol. 2018 Jul 25;9:973. doi: 10.3389/fphys.2018.00973. eCollection 2018.
7
Overexpression of preeclampsia induced microRNA-26a-5p leads to proteinuria in zebrafish.子痫前期诱导的 microRNA-26a-5p 过表达导致斑马鱼蛋白尿。
Sci Rep. 2018 Feb 26;8(1):3621. doi: 10.1038/s41598-018-22070-w.
8
Spectrum of Factors Triggering Endothelial Dysfunction in PIH.妊娠期高血压疾病中引发内皮功能障碍的因素谱
J Clin Diagn Res. 2016 Dec;10(12):BC14-BC17. doi: 10.7860/JCDR/2016/22113.9023. Epub 2016 Dec 1.
9
The effects of sildenafil citrate on urinary podocin and nephrin mRNA expression in an L-NAME model of pre-eclampsia.枸橼酸西地那非对先兆子痫L-NAME模型中尿足突蛋白和肾足蛋白mRNA表达的影响。
Mol Cell Biochem. 2017 Mar;427(1-2):59-67. doi: 10.1007/s11010-016-2897-5. Epub 2016 Dec 19.
10
From Glomerular Endothelium to Podocyte Pathobiology in Preeclampsia: a Paradigm Shift.子痫前期中从肾小球内皮细胞到足细胞的病理生物学:范式转变
Curr Hypertens Rep. 2015 Jul;17(7):54. doi: 10.1007/s11906-015-0566-9.
口服血管内皮生长因子受体抑制剂西地尼布引起的高血压和蛋白尿迅速发展。
Clin J Am Soc Nephrol. 2010 Mar;5(3):477-83. doi: 10.2215/CJN.08111109. Epub 2010 Jan 7.
4
Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension.重组血管内皮生长因子 121 输注降低胎盘缺血诱导高血压大鼠的血压并改善肾功能。
Hypertension. 2010 Feb;55(2):380-5. doi: 10.1161/HYPERTENSIONAHA.109.141937. Epub 2009 Dec 21.
5
Inhibition of tyrosine kinases by sunitinib associated with focal segmental glomerulosclerosis lesion in addition to thrombotic microangiopathy.舒尼替尼所致的酪氨酸激酶抑制与局灶节段性肾小球硬化病变有关,此外还有血栓性微血管病。
Nephrol Dial Transplant. 2010 Mar;25(3):1001-3. doi: 10.1093/ndt/gfp666. Epub 2009 Dec 16.
6
Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathies.血栓性血小板减少性紫癜(TTP)和其他血栓性微血管病。
Best Pract Res Clin Haematol. 2009 Dec;22(4):567-76. doi: 10.1016/j.beha.2009.07.004.
7
The balance of autocrine VEGF-A and VEGF-C determines podocyte survival.自分泌血管内皮生长因子-A(VEGF-A)和血管内皮生长因子-C(VEGF-C)的平衡决定了足细胞的存活。
Am J Physiol Renal Physiol. 2009 Dec;297(6):F1656-67. doi: 10.1152/ajprenal.00275.2009. Epub 2009 Oct 14.
8
Acute and transient podocyte loss and proteinuria in preeclampsia.子痫前期中急性和短暂性足细胞丢失及蛋白尿
Nephron Clin Pract. 2009;112(2):c65-70. doi: 10.1159/000213083. Epub 2009 Apr 18.
9
Renal effects of anti-angiogenesis therapy: update for the internist.抗血管生成治疗的肾脏效应:内科医生的最新资讯
Am J Med. 2009 Apr;122(4):322-8. doi: 10.1016/j.amjmed.2008.11.025.
10
Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib.舒尼替尼抑制VEGF通路继发的血栓性微血管病
Nephrol Dial Transplant. 2009 Feb;24(2):682-5. doi: 10.1093/ndt/gfn657. Epub 2008 Dec 2.